Bonesupport Holding AB (OSTO:BONEX)
kr 229 +8.8 (+4%) Market Cap: 15.00 Bil Enterprise Value: 14.57 Bil PE Ratio: 71.34 PB Ratio: 15.79 GF Score: 76/100

Q4 2024 Bonesupport Holding AB Earnings Call Transcript

Feb 25, 2025 / 09:00AM GMT
Release Date Price: kr382.8 (+13.12%)

Key Points

Positve
  • Bonesupport Holding AB (BOEUF) reported a strong sales growth of 49% year-on-year for Q4 2024, with net sales reaching SEK257 million.
  • The company achieved a record operating cash flow of SEK73 million, providing financial flexibility for future investments.
  • CERAMENT G sales reached SEK154 million, marking an increase of over 100% compared to the same quarter last year, highlighting successful market penetration.
  • A groundbreaking clinical study published in December 2024 showed that antibiotic-eluting CERAMENT significantly reduced the risk of death in diabetic patients with bone infections.
  • The company is launching a sales booster program to expand its market presence in underpenetrated areas in Europe, Australia, and Canada, indicating proactive growth strategies.
Negative
  • Sales in the UK were negatively impacted by political interference and NHS directives, causing a disruption in the prioritization of surgeries.
  • The company faced a bad debt provision of SEK5.2 million due to the bankruptcy of CarePoint Health, affecting financial results.
  • Sales and marketing expenses increased significantly, from SEK73.1 million to SEK109.3 million, impacting overall profitability.
  • There is ongoing pressure on pricing in various markets, including the UK, which could affect future revenue growth.
  • The company is facing challenges in expanding into the spine segment, with pre-clinical studies still ongoing and market introduction not expected until at least late 2025.
Operator

Welcome to Bonesupport year-end report 2024 presentation. (Operator Instructions) Now I will hand the conference over to CEO, Emil Billback; and CFO, Hakan Johansson. Please go ahead.

Emil Billback
Bonesupport Holding AB - Chief Executive Officer

Yeah. Thank you very much, operator, and welcome everyone to Bonesupport's Quarter 4, 2024 results call. My name is Emil Billback, and I'm making this broadcast as always together with Hakan Johansson, our CFO. We will use the next 25 to 30 minutes to guide you through the presentation of the second results and then we will open up the line for question and answers.

So we progressed to slide 2. Fine, so just for everyone to be clear that before we go into the actual presentation, we have some disclaimers that are covering any forward-looking statements that we will make today.

So next slide please. So we would like to begin by looking at some of the condensed highlights from the report that we released this morning. So overall, the quarter for sales were SEK257 million, which corresponds to a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot